US Speeds Research Into Psychedelics for Mental Health

A new executive order cuts red tape for scientists studying psychedelic compounds like MDMA and psilocybin as treatments for depression, PTSD, and addiction.

The breakthrough also includes $50 million for research into ibogaine, a powerful substance showing promise for opioid addiction.